BRAFTOVI

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: c5573733602dc41e
Drug Approval Canada Name: BRAFTOVI
Product Name: BRAFTOVI
Status: Marketed
Status Date: 2021-07-05
Original Market Date: 2021-07-05
Din: 02513099
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01EC03 ENCORAFENIB
Atc Name: l 01 ec 03
Aig Number: 0162787001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

ENCORAFENIB

75 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c5573733602dc41e

Type

Standard